Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Clinical Case Reports|March 12, 2025
Extremely Rare Isolated Small-Intestinal Polyp Diagnosed by Double-Balloon Endoscopy in an Asymptomatic Adult PatientKentaro Tominaga, Annenkov Alexey, Yuto Tanaka, et al.
Internal Medicine (Tokyo, Japan)|August 9, 2019
Massive Bleeding from a Small Intestinal Submucosal Tumor-like Arterial Malformation: An Unclassifiable Vascular Lesion Revealed by a Detailed Pathological EvaluationKazuhiro Ota, Junki Noda, Hiroshi Akutagawa, et al.
BMC Gastroenterology|May 16, 2013
Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled studyTakanori Kuramoto, Eiji Umegaki, Sadaharu Nouda, et al.
European Journal of Clinical Pharmacology|June 4, 2021
Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirinHiroyuki Tsujimoto, Yuki Hirata, Yasuhiro Ueda, et al.
Internal Medicine (Tokyo, Japan)|January 20, 2016
Multiple Mesenteric Panniculitis as a Complication of Sjögren's Syndrome Leading to IleusKazuki Kakimoto, Takuya Inoue, Ken Toshina, et al.
Internal Medicine (Tokyo, Japan)|March 7, 2015
Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?Toshihisa Takeuchi, Kazuhiro Oota, Satoshi Harada, et al.
DEN Open|November 30, 2022
A case of recurrent massive thickening of the gastric wall caused by pancreatitis of the gastric ectopic pancreas: Detailed pathogenesis based on imagingShun Sasaki, Kazuhiro Ota, Ryo Tanaka, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2019
Hemorrhagic Gastric Metastasis from Hepatocellular Carcinoma Successfully Treated Using Coil Embolization of the Left Gastric ArteryMichitaka Imai, Toru Ishikawa, Marina Okoshi, et al.
Digestion|February 3, 2018
Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication TherapyHaruhiko Ozaki, Satoshi Harada, Toshihisa Takeuchi, et al.
Journal of Gastroenterology|June 22, 2021
Administration of a standard dose of vonoprazan fumarate delays gastric emptying in Japanese healthy adults: a prospective clinical trialKazuhiro Ota, Toshihisa Takeuchi, Yuichi Kojima, et al.
Pageof 12